ACADIA PHARMACEUTICALS INC. Increase (Decrease) in Prepaid Expense and Other Assets
ACADIA PHARMACEUTICALS INC. (ACAD) reported Increase (Decrease) in Prepaid Expense and Other Assets of $3.85 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-02-26
- ACADIA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2017-12-31 was -$6.10M, a 430.80% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2017-09-30 was $6.51M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2016-12-31 was $1.84M, a 8281.82% increase year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2016-09-30 was -$1.74M, a 306.18% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $3.85M, a 76.82% decline from fiscal 2024.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $16.59M, a 6.23% decline from fiscal 2023.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $17.69M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.49M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $3.85M 10-K · filed 2026-02-26 | ||||||
| 2024-12-31 | $16.59M 10-K · filed 2026-02-26 | ||||||
| 2023-12-31 | $17.69M 10-K · filed 2026-02-26 | ||||||
| 2022-12-31 | -$2.49M 10-K · filed 2025-02-27 | ||||||
| 2021-12-31 | -$1.80M 10-K · filed 2024-02-28 | ||||||
| 2020-12-31 | $7.09M 10-K · filed 2023-02-28 | ||||||
| 2019-12-31 | -$2.12M 10-K · filed 2022-03-01 | ||||||
| 2018-12-31 | $12.27M 10-K · filed 2021-02-25 | ||||||
| 2017-12-31 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $413.00K derived: sum of 2 quarters · filed 2020-02-27 | $911.00K 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $6.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $7.01M 10-Q · filed 2017-11-07 | |||||
| 2017-06-30 | $498.00K 10-Q · filed 2017-08-08 | ||||||
| 2016-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $108.00K derived: sum of 2 quarters · filed 2019-02-27 | $2.62M derived: sum of 3 quarters · filed 2019-02-27 | $4.73M 10-K · filed 2019-02-27 | |||
| 2016-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $780.00K derived: sum of 2 quarters · filed 2017-11-07 | $2.89M 10-Q · filed 2017-11-07 | $2.91M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $4.62M 10-Q · filed 2017-08-08 | $4.64M derived: sum of 3 quarters · filed 2018-02-27 | $5.49M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $2.11M 10-Q · filed 2016-05-05 | $2.13M derived: sum of 2 quarters · filed 2018-02-27 | $2.97M derived: sum of 3 quarters · filed 2018-02-27 | $2.82M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $864.00K derived: sum of 2 quarters · filed 2018-02-27 | $712.00K derived: sum of 3 quarters · filed 2018-02-27 | $804.00K 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $842.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $690.00K derived: sum of 2 quarters · filed 2016-11-07 | $782.00K 10-Q · filed 2016-11-07 | -$177.00K derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | -$152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$60.00K 10-Q · filed 2016-08-04 | -$1.02M derived: sum of 3 quarters · filed 2017-02-28 | -$1.97M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $92.00K 10-Q · filed 2016-05-05 | -$867.00K derived: sum of 2 quarters · filed 2017-02-28 | -$1.82M derived: sum of 3 quarters · filed 2017-02-28 | -$633.00K derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | -$959.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$1.91M derived: sum of 2 quarters · filed 2017-02-28 | -$725.00K derived: sum of 3 quarters · filed 2017-02-28 | -$652.00K 10-K · filed 2017-02-28 | |||
| 2014-09-30 | -$954.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $234.00K derived: sum of 2 quarters · filed 2015-11-05 | $307.00K 10-Q · filed 2015-11-05 | $593.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.26M 10-Q · filed 2015-08-06 | $1.55M derived: sum of 3 quarters · filed 2016-02-29 | $2.57M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $73.00K 10-Q · filed 2015-05-07 | $359.00K derived: sum of 2 quarters · filed 2016-02-29 | $1.38M derived: sum of 3 quarters · filed 2016-02-29 | $616.00K derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.31M derived: sum of 2 quarters · filed 2016-02-29 | $543.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.48M 10-K · filed 2016-02-29 | $1.99M 10-K · filed 2014-02-27 | ||
| 2013-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $257.00K derived: sum of 2 quarters · filed 2014-11-10 | $1.20M 10-Q · filed 2014-11-10 | $1.91M 10-Q · filed 2013-11-06 | $1.43M derived: sum of 4 quarters · filed 2015-02-26 | ||
| 2013-06-30 | -$768.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $173.00K 10-Q · filed 2014-08-05 | $729.00K 10-Q · filed 2013-08-06 | $406.00K derived: sum of 3 quarters · filed 2015-02-26 | $607.00K derived: sum of 4 quarters · filed 2015-02-26 | ||
| 2013-03-31 | $941.00K 10-Q · filed 2013-05-07 | $1.17M derived: sum of 2 quarters · filed 2015-02-26 | $1.38M derived: sum of 3 quarters · filed 2015-02-26 | $1.34M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2012-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $434.00K derived: sum of 2 quarters · filed 2015-02-26 | $397.00K derived: sum of 3 quarters · filed 2015-02-26 | -$41.00K 10-K · filed 2015-02-26 | -$320.00K 10-K · filed 2013-03-12 | ||
| 2012-09-30 | $201.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $164.00K derived: sum of 2 quarters · filed 2013-11-06 | -$274.00K 10-Q · filed 2013-11-06 | $14.00K derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$475.00K 10-Q · filed 2013-08-06 | -$187.00K derived: sum of 3 quarters · filed 2014-02-27 | -$227.00K derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-03-31 | -$438.00K 10-Q · filed 2013-05-07 | -$150.00K derived: sum of 2 quarters · filed 2014-02-27 | -$190.00K derived: sum of 3 quarters · filed 2014-02-27 | -$420.00K derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2011-12-31 | $288.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $248.00K derived: sum of 2 quarters · filed 2014-02-27 | $18.00K derived: sum of 3 quarters · filed 2014-02-27 | $131.00K 10-K · filed 2014-02-27 | |||
| 2011-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | -$270.00K derived: sum of 2 quarters · filed 2012-11-05 | -$157.00K 10-Q · filed 2012-11-05 | -$2.16M derived: sum of 4 quarters · filed 2013-03-12 | |||
| 2011-06-30 | -$230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$117.00K 10-Q · filed 2012-08-08 | -$2.12M derived: sum of 3 quarters · filed 2013-03-12 | -$3.44M derived: sum of 4 quarters · filed 2013-03-12 | |||
| 2011-03-31 | $113.00K 10-Q · filed 2012-05-08 | -$1.89M derived: sum of 2 quarters · filed 2013-03-12 | -$3.21M derived: sum of 3 quarters · filed 2013-03-12 | ||||
| 2010-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$3.33M derived: sum of 2 quarters · filed 2013-03-12 | -$671.00K 10-K · filed 2013-03-12 | ||||
| 2010-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $1.33M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $2.66M 10-Q · filed 2011-08-10 | ||||||
| 2009-12-31 | -$1.01M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |